BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) — all Canadian products
7 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02060884 | BETNESOL RETENTION ENEMA 5MG/100ML | PALADIN PHARMA INC. | Enema | Rectal | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 5 MG | Cancelled Post Market | |
| 02063190 | BETNESOL TABLETS | SHIRE PHARMA CANADA ULC | Tablet (Effervescent) | Oral | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 0.5 MG | Cancelled Post Market | |
| 00176834 | CELESTONE REPETABS 1MG | SCHERING-PLOUGH CANADA INC | Tablet (Extended-Release) | Oral | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG | Cancelled Post Market | |
| 02238818 | DOM-GENTAMICIN-BETAMETHASONE | DOMINION PHARMACAL | Liquid | Ophthalmic; Otic | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Pre Market | |
| 00682217 | GARASONE OPHTHALMIC AND OTIC SOLUTION | MERCK CANADA INC | Solution | Ophthalmic; Otic | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market | |
| 00586706 | GARASONE OPHTHALMIC OINTMENT | MERCK CANADA INC | Ointment | Ophthalmic | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Post Market | |
| 02238819 | PMS-GENTAMICIN-BETAMETHASONE | PHARMASCIENCE INC | Liquid | Otic; Ophthalmic | BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) 1 MG; GENTAMICIN (GENTAMICIN SULFATE) 3 MG | Cancelled Pre Market |
Browse other molecules: